STRONGBRIDGE BIOPHARMA plc Lease, Cost
STRONGBRIDGE BIOPHARMA plc reported Lease, Cost of $288.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2021-03-03
- STRONGBRIDGE BIOPHARMA plc lease, cost for the quarter ending 2019-12-31 was $74.00K.
- STRONGBRIDGE BIOPHARMA plc lease, cost for the quarter ending 2019-09-30 was $98.00K.
- STRONGBRIDGE BIOPHARMA plc lease, cost for the quarter ending 2019-06-30 was $142.00K.
- STRONGBRIDGE BIOPHARMA plc lease, cost for the quarter ending 2019-03-31 was $143.00K.
- STRONGBRIDGE BIOPHARMA plc lease, cost for fiscal 2020 was $288.00K, a 36.98% decline from fiscal 2019.
- STRONGBRIDGE BIOPHARMA plc lease, cost for fiscal 2019 was $457.00K.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2020-12-31 | $288.00K 10-K · filed 2021-03-03 | |||
| 2019-12-31 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $172.00K derived: sum of 2 quarters · filed 2020-02-28 | $314.00K derived: sum of 3 quarters · filed 2020-02-28 | $457.00K 10-K · filed 2020-02-28 |
| 2019-09-30 | $98.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $240.00K derived: sum of 2 quarters · filed 2019-11-07 | $383.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $142.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $285.00K 10-Q · filed 2019-07-31 | ||
| 2019-03-31 | $143.00K 10-Q · filed 2019-05-01 |